Agomelatine

規格

138112-76-2CAS番号

629-727-7EC番号

N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamideIUPAC名

C15H17NO2化学式

243.3 g/mol分子量

Agomelatine; 138112-76-2; Thymanax; Valdoxan; S20098; S-20098; AGO-178; S 20098; Agomelatina; N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide; AGO178; DTXSID3057642; 137R1N49AD; N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; DTXCID4031431; agomelatinum; RefChem:110192; N06AX22; N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamide; N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide; Agomelatine [INN]; Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-; MFCD00916659; N-(2-(7-Methoxynaphth-1-yl)ethyl)acetamide; N-(2-(7-Methoxy-1-naphthalenyl)ethyl)acetamide; N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide; CHEMBL10878; Agomelatine (INN); NCGC00253646-01; Melitor; N-[2-(7-Methoxynaphth-1-Yl)Ethyl]Acetamide; AGO 178; Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-; N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide; Valdoxan (TN); SR-01000944938; Agomelatine [INN:BAN]; AGO178C; UNII-137R1N49AD; AWY; Agomelatine (Standard); AGOMELATINE [MI]; AGOMELATINE [MART.]; AGOMELATINE [WHO-DD]; GTPL198; MLS006011913; SCHEMBL114476; AGOMELATINE [EMA EPAR]; orb1226404; orb1308595; orb3141321; Agomelatine - Bio-X trade mark; SCHEMBL27844916; SCHEMBL29930659; Agomelatine, >=98% (HPLC); CHEBI:134990; GLXC-03028; HMS3604N09; HMS3648G18; HMS3654B07; HMS3753C13; HMS3884A07; HMS5079G21; ETB38944; MSK10883; Tox21_113772; BBL029084; BDBM50035179; EBC-11261; HY-17038R; PDSP1_001305; PDSP1_001784; PDSP2_001289; PDSP2_001767; s1243; STL237728; AKOS005145681; AC-3395; CCG-221950; CS-0740; DB06594; FA17244; KS-1247; SB19508; NCGC00253646-03; NCGC00253646-10; NCGC00253646-11; BA167079; HY-17038; SMR002530056; SY053050; A2606; A2658; CAS-138112-76-2; NS00007664; SW219177-1; D02578; AB01274769-01; AB01274769_02; EN300-7405421; F211829; L000528; N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide; Q395229; SR-01000944938-1; SR-01000944938-3; BRD-K84698278-001-03-4; F0001-2383; N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide(Agomelatine)別名